QUALITY OF LIFE IN PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS IN THE CONDITIONS OF TREATMENT WITH CHIMERIC MONOCLONAL ANTIBODIES TO TNF α

<strong></strong><em>The article presents results of study of inhibitor TNF<span class="st"> α</span> — infliximab — on quality of life in patients with juvenile arthritis, refractory to standard immunosuppressive treatment. In 1.5 months after the beginning o...

Full description

Bibliographic Details
Main Authors: R.V. Denisova, E.I. Alexeeva, V.Yu. Al'bitsky, I.V. Vinyarskaya, S.I. Valieva
Format: Article
Language:English
Published: "Paediatrician" Publishers LLC 2009-01-01
Series:Вопросы современной педиатрии
Online Access:http://vsp.spr-journal.ru:80/jour/article/view/1113